-
341
Giant Condyloma Acuminatum of Vulva in an HIV-Infected Woman
Published 2017-01-01“…The most common risk factor is immunosuppression with HIV; however, any other cause of immunodeficiency can be a predisposing factor. …”
Get full text
Article -
342
Exacerbation of Pulmonary Fibrosis Following Single Lung Transplantation
Published 2012-01-01“…Following single lung transplantation, patients receive maintenance immunosuppression, which could mitigate the development of acute exacerbations in the native lung. …”
Get full text
Article -
343
Potentially paraneoplastic glomerulopathies in a Brazilian cohort: a retrospective analysis
Published 2025-01-01“…The dose of the immunosuppressive agents among patients with neoplasms before or after immunosuppression was not statistically different. …”
Get full text
Article -
344
Macrophages in Tumor Microenvironments and the Progression of Tumors
Published 2012-01-01“…In most tumors, the infiltrated macrophages are considered to be of the M2 phenotype, which provides an immunosuppressive microenvironment for tumor growth. Furthermore, tumor-associated macrophages secrete many cytokines, chemokines, and proteases, which promote tumor angiogenesis, growth, metastasis, and immunosuppression. …”
Get full text
Article -
345
Skin Abscess due to Serratia marcescens in an Immunocompetent Patient after Receiving a Tattoo
Published 2015-01-01“…To our knowledge, this is the first reported case of a S. marcescens skin infection following a tattoo, in the absence of immunosuppression.…”
Get full text
Article -
346
Collecting Duct Carcinoma of the Native Kidney in a Renal Transplant Recipient
Published 2017-01-01“…To our knowledge, CDC in the setting of renal transplant and long-term immunosuppression has not been previously described.…”
Get full text
Article -
347
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
Published 2014-01-01“…Management of ganciclovir-resistant CMV may be complicated by nephrotoxicity which is commonly observed with recommended therapies and/or rejection induced by “indirect” viral effects or reduction of immunosuppression. Herein, we report a series of four high serologic risk (donor CMV positive/recipient CMV negative) kidney transplant patients diagnosed with ganciclovir-resistant CMV disease. …”
Get full text
Article -
348
Review of the Early Diagnoses and Assessment of Rejection in Vascularized Composite Allotransplantation
Published 2013-01-01“…Many of the challenges that have historically been limiting factors in transplantation, such as rejection and the morbidity of immunosuppression, remain challenges in VCA. Because of the accessibility of most VCA grafts, and the highly immunogenic nature of the skin in particular, VCA has become the focal point for cross-disciplinary approaches to developing novel approaches for some of the most challenging immunological problems in transplantation, particularly the early diagnoses and assessment of rejection. …”
Get full text
Article -
349
Innovative immunotherapies and emerging treatments in type 1 diabetes management
Published 2025-01-01“…Beta cell therapies, including islet transplantation, offer promising outcomes but face challenges related to immunosuppression and donor availability. Stem cell therapies, particularly using mesenchymal stem cells (MSCs) and autologous hematopoietic stem cells (HSCs), demonstrate potential in immune modulation and beta cell regeneration. …”
Get full text
Article -
350
Health-Related Quality of Life after Pediatric Liver Transplantation: A Qualitative Analysis of the Perspectives of Health Care Providers
Published 2017-01-01“…HCP identified elements that both enhance (improved physical health, peer relationship, and activities of daily living) and challenge (need for immunosuppression, transplant follow-up, and restrictions) the multidimensional domains of HRQoL. …”
Get full text
Article -
351
Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
Published 2011-12-01“…Genotype C/C (rs12979860) was present in 6 (40%) patients with complete EVR and in none of slow-responders (one-sided p=0.041).The groups of recipients with and without complete EVR were comparable with sex, age, pre-treatment viral load, immunosuppression (cyclosporine vs. tacrolimus), weight and body mass index, and mean ribavirin dose. …”
Get full text
Article -
352
De Novo Onset of Myasthenia Gravis after Kidney Transplantation
Published 2024-01-01“…This illness is surprising since immunosuppression after transplant is usually sufficient to prevent immune-mediated disease. …”
Get full text
Article -
353
Evaluation of CD4+ T Lymphocyte Counts to Predict Survival of ICU Patients with Sepsis Using Sepsis-3 Criteria: A Prospective Cohort Study
Published 2024-01-01“…Sepsis remains a major health condition with a high mortality rate that may be related to immunosuppression. T lymphocyte subsets may reflect the immune function of sepsis patients. …”
Get full text
Article -
354
Feasibility and Safety of Bariatric Surgery in High-Risk Patients: A Single-Center Experience
Published 2018-01-01“…., 2016) at least one of the following risk factors was met: age ≥ 70 years, body mass index (BMI) > 70 kg/m2, liver cirrhosis, end-organ failure, or immunosuppression by status after organ transplantation along with (Birkmeyer et al., 2010) at least two comorbidities associated with obesity. …”
Get full text
Article -
355
Modulatory Effects of Astragalus Polysaccharides on T-Cell Polarization in Mice with Polymicrobial Sepsis
Published 2015-01-01“…Treatments with 100 and 200 mg APS/kg BW reduced Treg populations and elicited a more-balanced Th1/Th2 response that consequently attenuated immunosuppression in polymicrobial sepsis. High-dose APS administration led to excessive responses of Th17 cells which may have adverse effects in sepsis-induced organ injury.…”
Get full text
Article -
356
Severe Disabling Myalgia as an Initial Presentation of Polyarteritis Nodosa
Published 2019-01-01“…With continuation of aggressive immunosuppression and rehabilitation for five months, the patient improved and was able to walk without support. …”
Get full text
Article -
357
Divergent Crosstalk Between Microglia and T Cells in Brain Cancers: Implications for Novel Therapeutic Strategies
Published 2025-01-01“…The precise mechanisms underlying microglial interactions with T cells and their contributions to immunosuppression remain incompletely understood. <b>Methods</b>: This review comprehensively examines the complex cellular dialogue between microglia and T cells in two prominent brain malignancies: primary glioblastoma and secondary brain metastases. …”
Get full text
Article -
358
The Role of Gut Microbiota in Tumor Immunotherapy
Published 2021-01-01“…Some bacteria help fight tumors by activating immunity, while some bacteria mediate immunosuppression to help cancer cells escape from the immune system. …”
Get full text
Article -
359
Microglia-secreted TNF-α affects differentiation efficiency and viability of pluripotent stem cell-derived human dopaminergic precursors.
Published 2023-01-01“…We first observed that transplanted human dopaminergic precursors into the striatum of immunosuppressed rats elicited an early and sustained activation of astroglial and microglial cells after 15 days' post-transplant. …”
Get full text
Article -
360
A Case of De Novo Antiglomerular Basement Membrane Disease Presenting during Pregnancy
Published 2021-01-01“…Fetal safety should be considered and risks thoroughly discussed with the patient when choosing an immunosuppressive regimen for this condition.…”
Get full text
Article